[1]
J. Farias, R. dos S. Rodrigues, and L. G. de Andrade, “THE INDISCRIMINATE USE OF SEMAGLUTIDE (OZEMPIC) FOR WEIGHT LOSS”, REASE, vol. 11, no. 11, pp. 4817–4829, Nov. 2025, doi: 10.51891/rease.v11i11.22299.